1. Home
  2. SHOO vs SUPN Comparison

SHOO vs SUPN Comparison

Compare SHOO & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$43.36

Market Cap

2.9B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$47.94

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOO
SUPN
Founded
1990
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
SHOO
SUPN
Price
$43.36
$47.94
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$42.14
$61.60
AVG Volume (30 Days)
1.2M
916.2K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
2.27%
N/A
EPS Growth
N/A
N/A
EPS
1.00
N/A
Revenue
$2,534,109,000.00
$392,755,000.00
Revenue This Year
$12.39
$22.70
Revenue Next Year
$5.90
$19.14
P/E Ratio
$43.78
N/A
Revenue Growth
11.00
N/A
52 Week Low
$22.26
$32.21
52 Week High
$47.11
$59.68

Technical Indicators

Market Signals
Indicator
SHOO
SUPN
Relative Strength Index (RSI) 56.26 54.04
Support Level $43.03 $47.48
Resistance Level $46.38 $52.24
Average True Range (ATR) 1.58 1.58
MACD 0.25 0.10
Stochastic Oscillator 85.20 38.42

Price Performance

Historical Comparison
SHOO
SUPN

About SHOO Steven Madden Ltd.

Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: